Integrins contribute to lymphopoiesis, whereas Toll-like receptors (TLRs) facilitate the myeloid replenishment during inflammation. The combined role of TLRs and integrin on hematopoiesis remains unclear. gp96 (grp94, HSP90b1) is an endoplasmic reticulum master chaperone for multiple TLRs. We report herein that gp96 is also essential for expression of 14 hematopoietic system-specific integrins. Genetic deletion of gp96 thus enables us to determine the collective roles of gp96, integrins, and TLRs in hematopoiesis. We found that gp96-null hematopoietic stem cells could support long-term myelopoiesis. B-and T-cell development, however, was severely compromised with transitional block from pro-B to pre-B cells and the inability of thymocytes to develop beyond the CD4 ؊ CD8 ؊ stage. These defects were cell-intrinsic and could be recapitulated on bone marrow stromal cell culture. Furthermore, defective lymphopoiesis correlated strongly with failure of hematopoietic progenitors to form close contact with stromal cell niche and was not the result of the defect in the assembly of antigen receptor or interleukin-7 signaling. These findings define gp96 as the only known molecular chaperone to specifically regulate T-and B-cell development. (Blood. 2010;115: 2380-2390)
Introduction
Integrins are a family of 24 ␣␤ heterodimers in vertebrates formed noncovalently by 18 ␣ and 8 ␤ integrins, of which 17 integrins are expressed in the hematopoietic system. 1,2 Known best for their adhesion properties, integrins also orchestrate signals between extracellular matrix and intracellular cytoskeletons in regulating diverse functions of cells, including proliferation and differentiation. However, despite the expression of integrins on hematopoietic stem cells (HSCs) and the role of integrins in HSC homing to the bone marrow (BM) niche, their function in hematopoiesis remains controversial. For example, although ␣4 integrin has been implicated in both T and B lymphopoiesis from fetal HSCs, 3, 4 it appears to play a less significant role in adult hematopoiesis. 5, 6 Furthermore, combined deletion of both ␤1 and ␤7 integrins, which are the only known partners of ␣4 integrin, causes no defect in either lymphopoiesis or myelopoiesis. 7 Genetic ␤2 integrin deficiency causes myeloid hyperplasia, including profound granulocytosis and splenomegaly, but no significant problems in hematopoiesis. 8 Clearly, both ␣4 and ␤2 integrins are involved in homing of HSCs in the BM and recruitment of leukocytes to sites of inflammation. 5, 9, 10 Although pan-integrin deficient system is now available, 11 no resolution of the roles of integrin in hematopoiesis has emerged.
Toll-like receptors (TLRs) are pattern recognition receptors that play important roles in sensing pathogen-associated molecular patterns from microbes, which are critical for host immune response. 12 More than 10 TLRs have been described in vertebrates, recognizing a spectrum of microbial moieties, such as endotoxin, flagellin, dsRNA, and DNA. In the steady state, TLRs do not contribute significantly to hematopoiesis, although TLRs on HSCs have been implicated in the replenishment/recruitment of myeloid cells in response to inflammation. 13, 14 TLRs and integrins do not share significant structural homology. Nevertheless, the folding and proper expression of many TLR and integrin family members are dependent on gp96, the heat shock protein 90 (HSP90) paralogue in the endoplasmic reticulum (ER). Deletion of gp96 leads to posttranslational loss of multiple TLRs (TLR1, TLR2, TLR4, TLR5, TLR6, TLR7, and TLR9) and several integrins (␤2, ␣4, and ␣V integrins), [15] [16] [17] although no study has probed the entire hematopoietic system-specific integrins for their dependence on gp96.
As a major ER luminal protein whose expression can be further induced by accumulation of misfolded proteins, gp96 is also thought to participate in the ER-unfolded protein response (UPR) 18 and ER-associated protein degradation, 19 and has been implicated to play a major "housekeeping" function to maintain protein homeostasis in the secretory pathway. 20 The discovery that gp96 seems to selectively fold TLRs and integrins [15] [16] [17] was unexpected, which raises the intriguing possibility that gp96 is evolved to play more specialized function in the multicellular organism.
In this study, we used tamoxifen (TAM)-inducible gp96 knockout (KO) mice to further map the clientele of gp96 and to study the roles of gp96 in hematopoiesis. Hematopoiesis is an attractive model system to elucidate the function of gp96, not only because of the possible roles of integrins and TLRs in the process, but also because of the importance of UPR in regulating several aspects of the immune system, such as B-cell development, 21 plasma cell differentiation, 22, 23 and dendritic-cell (DC) development and function. 24 We demonstrated that gp96 is essential for the expression of a majority of hematopoietic system-specific integrins. Unexpectedly, we found that gp96 null HSCs were able to engraft and initiate long-term hematopoiesis. We further revealed that deletion of gp96 led to a selective and stage-specific loss in both T and B lymphopoiesis, but not NK-cell development or myelopoiesis, underscoring that gp96 plays a specialized rather than a general role in hematopoiesis. Furthermore, because of the complete loss of multiple TLRs and integrins in gp96 null cells, we also conclude that the functional requirement of TLRs and integrins in hematopoieis is highly lineage-specific.
Methods
Mice C57BL/6 (CD45.2) mice were obtained from The Jackson Laboratory. C57BL/6 (CD45.1) mice were purchased from NCI-Frederick. hsp90b1 floxed mice were crossed to R26R-creERT2 mice (kindly provided by James Y. H. Li, University of Connecticut Health Center [UCHC]) and further backcrossed to C57BL/6 background for 6 to 10 generations. Control mice were hsp90b1 flox/flox -creER Ϫ littermates (designated as wildtype [WT]) of hsp90b1 flox/flox -creER ϩ KO mice. All mice were maintained by the Center for Laboratory Animal Care of UCHC (Farmington, CT) on an Institutional Animal Care and Use Committee-approved animal care protocol.
Cell lines
WT and gp96 mutant 70Z/3 pre-B cells were a gift from Brian Seed (Harvard University), 15 which were cultured in RPMI medium (SigmaAldrich) supplemented with 10% heat-inactivated fetal calf serum (Atlas Biologicals), 55M 2-mercaptoethanol (Invitrogen), and penicillinstreptomycin (Invitrogen). OP9 and OP9-DL1 cells were cultured in ␣-minimum essential medium containing L-glutamine and ribonucleotides (Invitrogen) supplemented with 20% fetal calf serum, 1mM sodlium pyruvate (Invitrogen), 10mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid (Invitrogen), 55M 2-mercaptoenthanol, and penicillinstreptomycin. All cells were cultured in 5% CO 2 incubator.
Tamoxifen-inducible gp96 deletion
Tamoxifen (Sigma-Aldrich; 100 g/20 g body weight) in peanut oil (Sigma-Aldrich) was administered by intraperitoneal injection daily for 12 to 14 consecutive days to both experimental and control mice, and deletion of gp96 was monitored by loss of CD11b on Gr1 ϩ cells in the peripheral blood leukocytes. Deletion of gp96 was also confirmed by immunoblot and by intracellular stain for gp96.
Flow cytometry
After Fc-receptor blocking, cells were stained for surface lineage markers. For Lin Ϫ Scal-1 ϩ c-Kit ϩ (LSK) population, lineage-negative (Lin Ϫ ) cells (CD3, CD4, CD8, CD5, B220, NK1.1, Gr1, F4/80, and Ter119) were analyzed for expression of Sca-1 and c-Kit. For gp96 intracellular staining, cells were stained for surface markers, then fixed in 4% formalin/phosphatebuffered saline, permeabilized using ice-cold MeOH. Nonspecific binding was blocked with 10% goat serum, and gp96 was stained intracellularly with rabbit IgG isotype control or SPA-851 polyclonal gp96 antibody (Stressgen), followed by anti-rabbit secondary antibody. All antibodies were purchased from eBioscience, except where indicated. Fluorescenceactivated cell sorter data were analyzed on FlowJo software (TreeStar) before being imported to ACD Systems Canvas.
Immunoblot
Single-cell suspension of BM cells, thymocytes, and splenocytes was lysed in RIPA buffer supplemented with proteinase inhibitor cocktail (SigmaAldrich) as described. 17 For all other organs, tissue was minced in lysis buffer and briefly sonicated. Bradford assay was used to quantitate protein concentration, and equal amounts of lysate were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. gp96 was detected using 9G-10 primary antibody (Stressgen) followed by horseradish peroxidaseconjugated anti-rat secondary antibody (Sigma-Aldrich). ␤-Actin was blotted (AC-74; Sigma-Aldrich) as a loading control.
BM transplantation
BM cells were isolated from both tibia and femur using aseptic technique. Red blood cells were lysed using sterile ammonium chloride lysis buffer, and BM cells were resuspended in sterile phosphate-buffered saline, pH 7.2, at 10 million cells/mL. A total of 2 million BM cells were injected via tail vein to irradiated C57BL/6 mice (550 cGy ϫ2, 4 hours apart, 1 day before BM transplantation). Recipients were monitored for hematopoietic reconstitution in peripheral blood leukocytes using CD3, B220, Gr1, and CD11b markers. Similarly, for 1:1 transplantation experiments, 2 million WT (CD45.1/CD45.2) and KO (CD45.2) BM was injected intravenously to lethally irradiated WT C57BL/6 (CD45.1) recipients. Six weeks after transplantation, TAM was administered intraperitoneally to induce gp96 deletion. For 20:1 transplantation experiments, 7 months post-TAM deletion (PTD), 10 million gp96 null BM cells (CD45.2) and 0.5 million WT C57BL/6 (CD45.1) BM cells were injected to lethally irradiated WT C57BL/6 (CD45.1) mice.
Enrichment of Lin
BM cells from WT and KO chimeras were isolated, stained using biotinylated lineage cocktail, and Lin ϩ cells were depleted using antibiotin MACs beads (Miltenyi Biotec). Subsequently, Lin Ϫ cells were stained with c-Kit-phycoerythrin (PE) antibody followed by positive selection using anti-PE MACS beads. Enrichment of progenitors was routinely verified by flow cytometry after staining with biotinylated lineage-specific antibody cocktail followed by streptavidin-allophycocyanin and Sca-1-fluorescein isothiocyanate. c-Kit-PE staining was maintained after positive selection. Purity was more than 85%.
OP9 and OP9-DL1 coculture
A total of 10 000 OP9 and OP9-DL1 were plated the day before to a 6-well plate. When the cells reached approximately 70% confluence, 1 ϫ 10 5 Lin Ϫ c-Kit ϩ progenitors were seeded on top in media supplemented with interleukin-7 (IL-7; 5 ng/mL; Biovision) and FLT3L (5 ng/mL; Biovision). Cocultures were refed every third day and split to a fresh stromal layer weekly. A small aliquot of cells was reserved for analysis of differentiation by flow cytometry.
Statistics
Numbers in all bar graphs represent mean plus or minus SD. The Student t test was used to determine whether the difference between 2 groups is statistically significant (P Ͻ .05).
Results
gp96 is essential for cell-surface expression of most hematopoietic system-specific integrins Loss of gp96 is embryonic lethal (e5.5). 25 To study the roles of gp96 in hematopoiesis, we generated TAM-inducible gp96 KO mice by crossing hsp90b1 flox/flox mice with Rosa26-creERT2 mice. After 14 days of daily injection with TAM, Cre-mediated deletion of gp96 from all adult tissues of KO mice was accomplished ( Figure 1A ; and data not shown). As expected, loss of gp96 led to abrogation of surface integrins CD11b, ␣4, and TLR2, but not a nonclient CD16/32 on hematopoietic cells ( Figure 1B) , consistent with the known chaperone functions of gp96. [15] [16] [17] Next, we systematically examined and compared the expression of all integrins in the hematopoietic system of KO mice and control littermates by flow cytometry. We found that gp96 is essential for cell surface expression of 14 of 17 integrin pairs (summarized in Figure 1C ). KO cells failed to express a majority of integrins except ␣5␤1, ␣6␤1, and ␣IIb␤3 integrins.
General lymphopoiesis, but not myelopoiesis, is dependent on gp96
gp96 is ubiquitously expressed in all tissues. To study the hematopoietic system-autonomous roles of gp96 in hematopoiesis, we used a BM chimera approach to generate chimeric mice that were deficient of gp96 only in the hematopoietic system ( Figure  2A ). WT recipient mice were lethally irradiated, followed by transplantation with either KO or WT BM cells. Chimeric mice were allowed to first establish multilineage reconstitution (6-8 weeks) before TAM treatment and deletion of gp96.
One month PTD, we confirmed the gp96 knockdown by immunoblot ( Figure 2B ) and intracellular stain ( Figure 2C ). There was a general leukocytosis at this point in the peripheral blood ( Figure 2D ). Red blood cell count was normal, although there was a evidence for thrombocytopenia ( Figure 2D ); the etiology of the latter is unclear and is being pursued in a separate study (M.S. and J.L., unpublished observation, May 2007). Noticeably, KO chimeras had markedly decreased cellularities in thymus and peripheral lymph nodes with modestly increased cellularities in the spleen and BM ( Figure 2E ). Although the absolute numbers of myeloid cells were well maintained over time in both the BM and spleen ( Figure  2F -G), there were severe T-and B-cell developmental blocks (discussed in Figure 5 ) that contributed to a significant reduction in mature peripheral B and T cells 7 months PTD ( Figure 2G ; and data not shown). We also examined the impact of gp96 loss on the development of DCs. 26 By costaining BM cells with c-Kit and c-FMS, we found that gp96 loss did not significantly alter the macrophage-DC progenitors in the BM (supplemental Figure 2A) . 27 Because of loss of CD11c, we used lineage gating to enumerate mature DCs. We noted that the splenic B220 Ϫ CD3 Ϫ CD5 Ϫ NK1.1 Ϫ F4/80 Ϫ MHCII ϩ (Lin Ϫ MHCII ϩ ) population that contains myeloid DCs (Ͼ 70% CD11c ϩ ) was similar between KO and controls (data not shown); likewise, the number and percentage of Lin Ϫ MHCII ϩ PDCA-1 ϩ plasmacytoid DCs were comparable (data not shown). Furthermore, both macrophage and DCs could be differentiated successfully in vitro from KO progenitors (supplemental Figure 2B -C), although KO macrophage clearly failed to adhere to the culture dish (supplemental Figure 2D ). Taken together, we conclude that myeloid lineage differentiation is surprisingly robust despite the disappearance of almost all integrins, multiple TLRs, and gp96 itself.
Hematopoietic progenitors persist in the absence of gp96, integrins, and TLRs
Normal myelopoiesis in the absence of gp96 suggests strongly that HSCs are able to self-renew and differentiate in a manner that is independent of gp96. This point was further validated experimentally. We first confirmed the loss of gp96 in the LSK population, which contains HSCs (long-term and short-term) and early lymphoid progenitors, and Lin Ϫ Sca-1 Ϫ c-Kit ϩ progenitors (PROG), which include mostly myeloid progenitors. 28 Loss of gp96 was observed in both these populations and was concomitant with the loss of ␣4 (CD49d), ␣L (CD11a) integrin and TLR2 expression ( Figure 3A -C). We observed a significant expansion in both percentage and numbers of LSK and, to a lesser extent, PROG in KO BM ( Figure 3D ). Consistent with the robust myelopoiesis of KO cells in vivo, colony-forming unit cultures in semisolid methylcellulose demonstrated no differences in overall myeloid/ erythroid differentiation potential between WT and KO BM cells (data not shown).
We next sought to more closely examine the effects of loss of gp96 on progenitor populations in the BM and thymus. We focused primarily on the early lymphoid progenitor (Lin Ϫ Sca-1 ϩ c-Kit ϩ FLT3 ϩ ) and early thymic progenitor populations (Lin Ϫ CD25 Ϫ c-Kit ϩ ) that are derived from FLT3 ϩ LSK. [29] [30] [31] [32] [33] We found that LSK/PROG was increased in the peripheral blood and spleen of gp96 KO chimeras ( Figure 3E ), which were maintained upwards 7 months PTD ( Figure 3D ; and data not shown). Interestingly, the increase in both LSK percentage and number in KO chimeras was predominately of FLT3 Ϫ/lo that contains HSCs and multipotent progenitors ( Figure 3F ). 30 However, although the percentage of BM FLT3 ϩ LSK was reduced, the absolute numbers of FLT3 ϩ LSK were comparable because of an increase in the overall numbers of BM KO LSK. In addition, the percentage of BM common lymphoid progenitors (CLPs; Lin Ϫ Sca-1 Ϫ c-Kit lo IL-7R␣ ϩ ) was also comparable between WT and KO 1 month PTD (supplemental Figure 3A) . Consistent with the persistence and function of BM CLPs, we found that NK cell developed normally in the absence of gp96 (supplemental Figure 3B-C) .
gp96 KO BM cells were unable to rescue lethally irradiated mice (supplemental Figure 4) , which could be the result of poor engraftment. To circumvent this problem and to further address the impact of gp96 loss on long-term hematopoiesis, we performed secondary BM transplantation with a mixture of KO and WT BMs in a 20:1 ratio ( Figure 4A) . WT (CD45.1) and KO (CD45.2) donor cells were congenically marked for easy distinction ( Figure 4B ). We found that gp96 KO BM cells were able to engraft, albeit not as efficiently as WT BM cells (ϳ 80-fold less efficient based on BM cellularity; Figure 4C -F). Consistent with single donor chimera experiments, KO cells were restricted in their hematopoietic potential and favored myelopoiesis over lymphopoiesis ( Figure  4E-F) . Cells in the "other" category in KO BM and spleen were probably of myeloid origin, such as F4/80 ϩ cells, which develop normally in the absence of gp96 ( Figure 2F ). We therefore conclude that the maintenance or survival of HSCs in vivo is independent of gp96 and its client network including integrins and TLRs.
gp96 is critical for pro-pre-B-cell transition
We next focused our attention on defining the critical developmental stages of B and T lymphocytes that were controlled by gp96. gp96 KO chimeras were found to have a profound block in B lymphopoiesis at B220 lo IgM Ϫ stage, as evidenced by a marked reduction in the percentage and number of B220 lo IgM ϩ cells and a complete absence of B220 hi IgM ϩ recirculating B cells at 1 month and 7 months PTD ( Figure 5A-B) . More specifically, we noted a significant developmental blockade at the B220 ϩ CD43 ϩ CD24 lo stage at the transition from c-Kit ϩ to CD25 ϩ corresponding to a defect in late pro-B to early pre-B-cell transition ( Figure 5C ; supplemental Figure 5A ). 34 Of note, splenic B-cell numbers were maintained in gp96 KO BM chimeras early PTD, which indicated that once B cells matured, they no longer require gp96 for maintaining homeostasis, which was in line with our previous study. 17 However, B-cell number did decline significantly by 7 months PTD ( Figure 2G ). Consistent with earlier work, 17,35 KO mice had additional loss of the splenic marginal zone B cells resulting from integrin-mediated retention defect (supplemental Figure 5B-C) .
Before acquisition of B-cell receptor (BCR), developing B cells express a pre-BCR, composed of Vpre-B and 5 that comprise the surrogate light chain on a H backbone. 36 Expression of pre-BCR further defines the transition between pro-and pre-B-cell stages and has been shown to be an important checkpoint in pre-B proliferation and differentiation. 37,38 5 expression on a gp96 null pre-B cell line was, however, equivalent to WT cells ( Figure 5D ). Comparable expression of 5 was also confirmed on B220 lo IgM Ϫ pre-B cells in WT and KO chimeras (data not shown), thus excluding a role for gp96 in pre-BCR assembly.
Given the important role of IL-7R in B-and T-cell development, we next examined the role of gp96 on IL-7R␣ expression and signaling. IL-7R␣ was uncompromised on gp96 null pre-B cells ( Figure 5D ). Furthermore, IL-7 stimulation of gp96 null and control pre-B cells led to equal phosphorylation of Stat-5 (supplemental Figure 6 ). In addition, IL-7R␣ expression on gp96 null leukocytes and on CLPs was normal (data not shown).
gp96 is essential for effective thymopoiesis
Analogous to B-cell development blockade with gp96 KO chimeras, at 1 month PTD, we observed a marked reduction of thymic cellularity ( Figure 2D) . Thymopoiesis begins at the CD4 Ϫ CD8 Ϫ double-negative (DN) stage that can be defined by differences in expression of CD44 and CD25 surface markers, where the earliest stage DN1 population (CD44 ϩ CD25 Ϫ ) also encompasses c-kit hi early thymic progenitors (ETPs), 39 followed by DN2 (CD44 ϩ CD25 ϩ ), DN3 (CD44 Ϫ CD25 ϩ ), and DN4 (CD44 Ϫ CD25 Ϫ ) stages. 40 gp96 KO thymocytes have a developmental blockade at the DN1 stage ( Figure 5E-F) , which strongly correlated with thymic atrophy (supplemental Figure 7A) . By 7 months PTD, thymopoiesis was virtually nonexistent in KO mice ( Figure 5G ). DN3 thymocytes, similar to pre-B cells, express a pre-T-cell receptor (pre-T␣), which corresponds to transition through DN3 stage. We were able to analyze pre-T␣ expression in KO thymocytes early after gp96 deletion and before the loss of DN3 thymocytes; we found that these KO cells express normal levels of pre-T␣ (data not shown), arguing against a defect in pre-T-cell receptor assembly in KO mice. In addition, gp96 KO mice crossed to T-cell receptor transgenic OT-I Rag1 Ϫ/Ϫ mice were not able to rescue thymic development (data not shown). Consistent with the role of ␣4 and ␤2 integrins in ETP homing to the thymus, 41 the percentage and absolute numbers of ETPs (Lin Ϫ CD25 Ϫ c-kit ϩ ) were reduced in KO mice (supplemental Figure 7B) . Immunofluorescence microscopy of c-Kit ϩ CD25 ϩ DN thymocytes 42 confirmed their near-complete absence from KO thymus (supplemental Figure  7C) . The reduction but persistence of other DN cells such as c-Kit Ϫ population 1 to 2 months after gp96 deletion was probably the result of DN1-DN2 transitional block. Thus, the systematic loss of thymopoiesis involves both the DN1 to DN2 transitional block and a decrease in the migration/seeding of KO ETPs in the thymus over time.
Loss of B and Tymphopoiesis in gp96 null mice is cell intrinsic
Our previous mixed chimera experiment using 20:1 combination of KO to WT BM donors suggests that the lymphopoietic defect after gp96 loss is cell intrinsic (Figure 4) . However, those data were confounded by the poor homing or engraftment of gp96 null BM precursors. To further determine whether the developmental defects in T and B lymphopoiesis were cell intrinsic, we made 1:1 chimeras in which we cotransplanted BM from congenic WT and KO mice ( Figure 6A ). In contrast to 20:1 experiments using gp96 null BM cells, we waited for a full reconstitution of recipient mice before inducing gp96 deletion. If the developmental block of KO cells was the result of loss of soluble cell-extrinsic factors but not a cell-intrinsic mechanism, the presence of WT cells should rescue the defect. At 2 weeks PTD, KO and WT cells constituted similar percentage contributions to total BM cellularity and commitment to the Gr1 ϩ and F4/80 ϩ populations; however, 2 months PTD, the balance in total BM cellularity and myeloid populations clearly favored KO donors ( Figure 6B-C) . This was in contrast to the BM B220 ϩ IgM ϩ B cell pool in which we observed a competitive disadvantage by KO cells at all time points (Figure 6D -E; and data not shown). Likewise, we observed that KO thymocytes arrested at the DN stage, 2 weeks PTD, reaffirming an early intrathymic developmental defect and a comprehensive loss in thymocytes in KO mice over time ( Figure 6F-G) . Total DN thymocytes of KO origin also progressively declined to less than 5% of the entire DN thymocytes 4 months PTD (data not shown), which was consistent with the additional homing defect of KO ETPs. Thus, gp96 regulates B and T lymphopoiesis in a cell-intrinsic fashion. In addition, despite the presence of a WT competitor, gp96 LSK and progenitors were well sustained in the BM, and their percentage and number were consistently increased. Moreover, gp96 LSK and PROG were capable of long-term myelopoiesis upward 9 months PTD even in this competitive setting (data not shown).
gp96 null hematopoietic progenitors proliferate poorly and fail to differentiate into B and T cells on stromal cells in vitro
The failure of gp96 KO cells to differentiate along T-and B-cell lineages in vivo could be the result of a defect in the intrinsic developmental program or to the inability of progenitors to migrate into the proper niche, or both. To examine these possibilities, we performed an in vitro differentiation assay using a well-described B-and T-cell developmental coculture system. The stromal cell line OP9, and OP9-DL1, which expresses notch ligand Delta-like 1 (DL1), have been used to effectively drive B-and T-cell differentiation, respectively. 43 We purified Lin Ϫ c-Kit ϩ progenitors from WT and KO BM (supplemental Figure 8) and plated equal numbers of cells onto OP-9 and OP9-DL1 in culture. Cells were then enumerated and analyzed by flow cytometry at weekly intervals. We found that KO cells proliferated poorly on both OP-9 and OP9-DL1 ( Figure 7A-B) , with little evidence of B-and T-cell differentiation ( Figure 7C-D) . Moreover, gp96 KO progenitors were unable to transmigrate beneath stromal cells to form prototypical "cobblestone" colonies ( Figure 7E ), a sign of an early differentiation program. 4 The inability of KO cells to transmigrate through BM stromal layers was also recapitulated quantitatively using a gp96 mutant pre-B-cell line (supplemental Figure 9) .
Discussion
gp96 is a ubiquitously expressed and evolutionarily conserved ER-resident molecular chaperone belonging to the HSP90 family. 20 Genetic and biochemical approaches have demonstrated the pivotal role of gp96 in folding and maturation of TLRs and integrins. [15] [16] [17] In addition, as a canonical member of the HSP90 family, gp96 participates in a variety of molecular and biochemical processes to maintain protein homeostasis in the ER. 19 Thus, the functional importance of gp96 in hematopoiesis could be at least 2-fold, insomuch as it participates in the folding/maturation of 2 very important classes of immunologically relevant molecules, and it also serves a second perhaps more general housekeeping role in ER protein homeostasis.
Full appreciation of the function of gp96 requires knowledge of gp96 client proteins, whose expression is dependent on gp96. In this study, we significantly expanded on the gp96 client network by determining the differential expression of integrins by WT and gp96 KO hematopoietic cells. We found that gp96 is essential for the expression of a majority of integrins, including ␣1, ␣2, ␣4, ␣D, ␣E, ␣L, ␣M, ␣V, and ␣X of the hematopoietic system. Because ␣ integrin must heterodimerize with its appropriate ␤ integrin partner for cell surface expression, we conclude that gp96 is crucial for the expression of 14 of 17 integrin pairs expressed by the hematopoietic system. The requirement for gp96 in folding these integrins is absolute and cannot be compensated by any other ER chaperones. Although the structural basis for selective dependence on gp96 by integrins is unclear, it is intriguing to point out that the loss of all ␤ integrins can be explained by the loss of their corresponding ␣ partners, but not the converse. By deduction, we postulate that gp96 is critical for chaperoning ␣, but not ␤, subunits of integrins.
The loss of multiple TLRs and integrins in gp96 null mice created an unprecedented opportunity to address their combinational roles in hematopoiesis. Using a TAM-inducible gp96 deletion system coupled with competitive BM reconstitution, we found that gp96 is surprisingly not required by HSCs to self-renew and to initiate long-term hematopoiesis along the myeloid lineage. gp96 is, however, required at defined critical stages of early T-and B-cell development, which correlated with the inability of gp96 KO progenitors to transmigrate BM stromal cell layers.
The underlying mechanism by which gp96 selectively regulates lymphopoiesis is not entirely clear. TLRs have been suggested to function in replenishment of the myeloid compartment after bacterial infection. 13 Furthermore, although TLRs were not directly examined, inflammation can affect lymphoid versus myeloid distribution in favor of the latter. 44 However, the role of TLRs in hematopoiesis in the steady state is limited, evidenced by uncompromised B-cell development in MyD88 and Trif double KO mice, which lack all known TLR downstream signaling. 45 It is thus unlikely that the loss of TLRs contributes significantly to the lymphopoietic defect in gp96 KO mice. In contrast, the role for integrins in hematopoiesis is extensive, particularly related to the function of ␣4 and ␤2 integrins, both of which are bona fide clientele of gp96. Like gp96, ␣4 integrin is essential for embryogenesis and is also required for both early B-and T-cell development in fetal liver chimeric mice. 3, 4 It is required for stromal cell adhesion by both B-and T-cell progenitors, 4,46-48 correlating with its probable role in lymphopoiesis. However, transplantation of adult ␣4 null BM cells to irradiated Rag2 Ϫ/Ϫ mice revealed only partial defect in thymopoiesis and a decrease in certain subsets of BM B cells. 6 Conditional ablation of ␣4 or ␤1/␤7 integrin from adult mice had little infringement on lymphopoiesis. 5, 7, 49 These studies highlight that the roles of gp96 in early lymphopoiesis probably extend beyond chaperoning ␣4 and ␤2 integrins, and implicate that other members of integrins or/and yet unidentified gp96 clients also play a role in regulating lymphopoiesis.
In gp96 KO BM chimeras, B-and T-cell differentiation is arrested at developmentally analogous stages, pro-B-pre-B and DN1-DN2 transitions, respectively. Two obvious possibilities have been ruled out: the roles of gp96 in the assembly/function of antigen receptor and IL-7R. In addition, annexin V and propidium iodide staining of DN thymocytes subsets did not reveal any significant increase in apoptosis of gp96 null leukocytes (data not shown). Rather, KO cells appear to lose their tight interaction with developmental niche in the BM stromal cells, a scenario that can be explained by the role of gp96 in chaperoning integrins. Consistent with this idea, we observed an increase in LSKs, progenitors, and pro-B cells (B220 ϩ CD43 ϩ ) in the peripheral blood and spleen of gp96 KO chimeras. However, despite increased BM precursors in the periphery, we found no evidence of significant extramedullary hematopoiesis in KO chimeras.
Finally, our BM stromal cell cultures allowed us to conclude that the lymphopoietic defect of gp96 KO HSCs is not simply the result of poor seeding of progenitors in the BM and the thymus.
However, gp96 KO progenitors clearly had difficulty in transmigrating the stromal cell layer, arguing strongly that KO hematopoietic precursors might be unable to form an optimal niche locally to initiate lymphopoiesis at an early stage, despite appropriate differentiation cytokines and other cues. More work is necessary to define the critical downstream signals that are missing in gp96 null cells at the pre-B-and pre-T-cell stages and the coordinate function of integrins in these processes, although it is tempting to speculate that stromal contact and signals in general are a prerequisite for development of lymphoid but not myeloid compartments; such a claim warrants further investigation.
There have been increased interests in the roles of protein folding chaperones in hematopoiesis, a highly regulated process with simultaneous proliferation and multilineage differentiation that are probably dependent on robust protein chaperone machinery. However, deletion of individual molecular chaperone has not resulted in catastrophic loss of hematopoiesis. For example, in mice with loss of critical UPR regulator XBP1 or ATF6, hematopoiesis proceeds normally. Only plasma differentiation was affected with loss of XBP-1 and ATF6, [21] [22] [23] which may be related in part to the importance of downstream effector chaperone GRP78 in immunologlobulin assembly. 50 Loss of heat shock factor-1, a major transcription factor for HSPs, resulted in ablation of induction of HSPs 51 but no noticeable compromise of hematopoiesis. 52 Deletion of calreticulin causes heightened immune response resulting from aberrant activation of peripheral T cells. 53 Although genetic deletion of GRP78 and calnexin has been done, and it has revealed the critical importance of these 2 molecules in embryogenesis 54 and postnatal survival, 55 no specific roles of either molecule on hematopoiesis have been reported. Likewise, cytosolic HSP70 also appeared to be dispensable for hematopoiesis. 56 Thus, with the exception of lymphopoiesis defect in gp96 null mice, hematopoiesis and in particular myelopoiesis does not subject to tight regulation by the protein chaperone machinery, underscoring the possibility that myelopoiesis is vital to the survival of high vertebrates and is hardwired to withstand environmental and intracellular stress. These arguments also once again highlight the uniqueness of gp96 in hematopoiesis.
In conclusion, we have demonstrated that the expression of a majority of the hematopoietic system-specific integrins is controlled by gp96; thus, gp96 is a master chaperone for both TLRs and integrins. Yet, gp96 and its client network are dispensable for self-renewal and differentiation of HSCs. We further uncovered the dramatic difference between lymphopoiesis and myelopoiesis in their requirement for gp96. Our study thus illustrates that the developmental requirement for gp96 and its client network in hematopoiesis is both lineage-and stage-specific, highlighting that gp96 plays more specialized rather than general roles in regulating protein homeostasis in the ER and the secretory pathway. High resolution mapping of the gp96 client network is the essential next step to understand the function/mechanism of gp96 in hematopoiesis and to identify key downstream molecules in regulating lineage decision of lymphopoiesis versus myelopoiesis. Figure 1C ; J.C.Z.-P. generated Figure 7 and critically read the manuscript; H.L.A. generated supplemental Figure 3 ; I.G. critically read the manuscript; Z.L. conceived the idea, designed the research, and wrote the manuscript; and all authors contributed to the analysis of the data.
Conflict-of-interest disclosure: The authors declare no competing financial interests.a very high risk for imminent heart failure. 1 Cardiac T2* studies have also dispelled the notion of a consistently close relationship between liver and cardiac iron, 2 and have established direct measurement of cardiac iron as a (if not the) critical outcome in assessing the efficacy of iron chelation therapy.
As a result, we are now gaining increasing clarity about the effects on the heart of the 3 iron chelators that are available in different parts of the world. In randomized, controlled clinical trials in patients with thalassemia and mild to moderate cardiac iron overload, deferiprone, still unlicensed in North America but widely available elsewhere, has proven more effective than deferoxamine in improving cardiac T2* and ejection fraction, 3 and the combination of deferiprone and deferoxamine has proven more effective than deferoxamine alone in improving cardiac T2* and ejection fraction. 4 Combined therapy with deferiprone and deferoxamine has been similarly effective in the particularly vulnerable patients with severe cardiac iron overload and low ejection fractions. 5 These studies support important earlier observations about the effectiveness of deferiprone in preventing cardiac death in patients with thalassemia. 6 The present multicenter, prospective study of the newest iron chelator, deferasirox, by Pennell et al evaluates changes in cardiac T2* and ejection fraction over 12 months in a large cohort of patients with thalassemia and ejection fractions of 56% or higher. 7 In patients with cardiac iron overload (T2* 5-20 ms), the mean T2* improved from 11.2 ms to 12.9 ms; increases occurred in 70% of patients. In patients without significant cardiac iron overload (baseline T2* values Ͼ 20 ms), the mean T2* did not deteriorate, and no patient fell below 20 ms at the end of the study. In contrast to the earlier studies of deferiprone, the mean ejection fraction did not improve in patients with cardiac iron overload treated with deferasirox, although improvement occurred in patients with normal cardiac iron.
The dosing of deferasirox in this trial deserves particular attention. Novartis recommends a starting dose of 20 mg/kg/day. However, most patients with cardiac iron overload began the study at a deferasirox dose of 30 mg/kg/day. By the end of the study, 63% required 40 mg/kg/day, the highest currently approved dose, to reduce cardiac iron. Most patients without increased cardiac iron entered the study at a dose of 20 mg/kg/day, but almost one-half required 40 mg/kg/day of deferasirox to maintain a normal cardiac T2*. These dose requirements support the experience of clinicians that patients with thalassemia frequently need a higher dose of deferasirox and excellent compliance to remove excessive iron or to prevent further iron accumulation. Fortunately, the safety profile of deferasirox at a dose of 40/mg/kg/day resembles the profile at lower doses. However, the cost of the higher doses approaches $80 000 per year for an adult and dramatically widens the gap between the cost of deferasirox and other chelators. 8 Compliance must be watched very carefully, as it is generally poorer outside of clinical trials.
What additional studies will help clinicians and patients navigate the historically stormy waters of iron chelation therapy? The authors point out that a study comparing deferasirox and deferoxamine is currently under way. Although deferoxamine as a daily subcutaneous infusion has proven to be a very effective chelator, the widespread adoption of orally active chelators suggests that the days of deferoxamine as monotherapy are largely over. With 2 orally active chelators now available and with tools for noninvasive measurement of cardiac iron now accessible, studies of new combinations of chelators and a direct comparison of the effectiveness of deferiprone and deferasirox in addressing cardiac iron and improving survival will likely guide the future management of transfusional iron overload.
Conflict-of-interest disclosure: A.R.C. serves on a DSMB for ApoPharma for which he receives reimbursement for meeting-related expenses. ■ I nitially identified as a glucose-regulated protein, gp96 (also referred to as grp94 or tumor rejection antigen 1) is an abundant endoplasmic reticulum protein with multiple biologic functions. 2 As a chaperone molecule during protein folding, gp96 is up-regulated during cell stress and plays a key role in unfolded protein responses (UPR). When released into the extracellular milieu after necrosis, soluble gp96 can function as an adjuvant for antitumor immune responses and can activate macrophages through Toll-like receptor 2 (TLR2). In addition, gp96 can bind short peptides and
